DICP OpenIR
Discovery and Validation of Plasma Biomarkers for Major Depressive Disorder Classification Based on Liquid Chromatography-Mass Spectrometry
Liu, Xinyu1; Zheng, Peng2,3; Zhao, Xinjie1; Zhang, Yuqing2,3; Hu, Chunxiu1; Li, Jia1; Zhao, Jieyu1; Zhou, Jingjing2,3; Xie, Peng2,3; Xu, Guowang1
刊名JOURNAL OF PROTEOME RESEARCH
2015-05-01
DOI10.1021/acs.jproteome.5b00144
14期:5页:2322-2330
收录类别SCI
文章类型Article
WOS标题词Science & Technology ; Life Sciences & Biomedicine
类目[WOS]Biochemical Research Methods
研究领域[WOS]Biochemistry & Molecular Biology
关键词[WOS]OXIDATIVE STRESS ; RAT MODEL ; PREFRONTAL CORTEX ; SURROGATE MARKER ; MOOD DISORDERS ; MILD STRESS ; ACETYLCARNITINE ; METABOLOMICS ; METABOLISM ; CARNITINE
英文摘要Major depressive disorder (MDD) is a debilitating mental disease with a pronounced impact on the quality of life of many people; however, it is still difficult to diagnose MDD accurately. In this study, a nontargeted metabolomics approach based on ultra-high-performance liquid chromatography equipped with quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF/MS) was used to find the differential metabolites in plasma samples from patients with MDD and healthy controls. Furthermore, a validation analysis focusing on the differential metabolites was performed in another batch of samples using a targeted approach based on the dynamic multiple reactions monitoring method. Levels of acyl carnitines, ether lipids, and tryptophan pronouncedly decreased, whereas LPCs, LPEs, and PEs markedly increased in MDD subjects as compared with the healthy controls. Disturbed pathways, mainly located in acyl carnitine metabolism, lipid metabolism, and tryptophan metabolism, were clearly brought to light in MDD subjects. The binary logistic regression result showed that carnitine C10:1, PE-O 36:5, LPE 18:1 sn-2, and tryptophan can be used as a combinational biomarker to distinguish not only moderate but also severe MDD from healthy control with good sensitivity and specificity. Our findings, on one hand, provide critical insight into the pathological mechanism of MDD and, on the other hand, supply a combinational biomarker to aid the diagnosis of MDD in clinical usage.
语种英语
WOS记录号WOS:000354004700030
引用统计
文献类型期刊论文
条目标识符http://cas-ir.dicp.ac.cn/handle/321008/146252
专题中国科学院大连化学物理研究所
作者单位1.Chinese Acad Sci, Dalian Inst Chem Phys, Key Lab Separat Sci Analyt Chem, Dalian 116023, Peoples R China
2.Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing 400016, Peoples R China
3.Chongqing Med Univ, Inst Neurosci, Chongqing 400016, Peoples R China
推荐引用方式
GB/T 7714
Liu, Xinyu,Zheng, Peng,Zhao, Xinjie,et al. Discovery and Validation of Plasma Biomarkers for Major Depressive Disorder Classification Based on Liquid Chromatography-Mass Spectrometry[J]. JOURNAL OF PROTEOME RESEARCH,2015,14(5):2322-2330.
APA Liu, Xinyu.,Zheng, Peng.,Zhao, Xinjie.,Zhang, Yuqing.,Hu, Chunxiu.,...&Xu, Guowang.(2015).Discovery and Validation of Plasma Biomarkers for Major Depressive Disorder Classification Based on Liquid Chromatography-Mass Spectrometry.JOURNAL OF PROTEOME RESEARCH,14(5),2322-2330.
MLA Liu, Xinyu,et al."Discovery and Validation of Plasma Biomarkers for Major Depressive Disorder Classification Based on Liquid Chromatography-Mass Spectrometry".JOURNAL OF PROTEOME RESEARCH 14.5(2015):2322-2330.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Liu, Xinyu]的文章
[Zheng, Peng]的文章
[Zhao, Xinjie]的文章
百度学术
百度学术中相似的文章
[Liu, Xinyu]的文章
[Zheng, Peng]的文章
[Zhao, Xinjie]的文章
必应学术
必应学术中相似的文章
[Liu, Xinyu]的文章
[Zheng, Peng]的文章
[Zhao, Xinjie]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。